Market release
2 February 2018
Notice to shareholders - Change of auditor
AFT Pharmaceuticals (AFT) board of directors have appointed Deloitte as the
auditor of the AFT Pharmaceutical Group, effective 2 February 2018. As AFT
continues to expand its product line and markets, Deloitte''s extensive
pharmaceutical company experience will provide audit services to support our
global expansion.
The appointment follows the resignation of PricewaterhouseCoopers (PwC) as
auditor of the AFT Pharmaceutical Group, also effective 2 February 2018. PwC
continues to be available for other advisory work for AFT.
PwC have been the auditor of AFT for the past ten years and AFT appreciates
and thanks PwC for their expertise and support during this time.
End of release
For more information:
Hartley Atkinson
Managing Director, AFT Pharmaceuticals Ltd
Phone +64 9 488 0232
End CA:00313697 For:AFT Type:AUDITORS Time:2018-02-02 08:31:09